Koios Medical, Inc. — Form D
Koios Medical, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-03. The offering totals $3.0M, of which $280K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-03
- Form: D
- Accession: 0001764417-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $280K
- Remaining: $2.7M
- Investors: 7
- Date of first sale: 2021-01-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-388280
Issuer
- Name: Koios Medical, Inc.
- CIK: 0001764417
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 242 W. 38TH STREET, NEW YORK, NY, 10018
- Phone: 732-529-5755
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| ROBERT CHAD MCCLENNAN | Director | NEW YORK, NY |
| CHRISTINE CHAD LI | Director | SINGAPORE, U0 |
| GREGORY CHAD MORAN | Director | COLUMBUS, OH |
| ROBERT CHAD MCCLENNAN | Executive Officer | NEW YORK, NY |
| ROBERT CHAD MCCLENNAN | Promoter | NEW YORK, NY |
| GRAHAM ANDERSON | Executive Officer | NEW YORK, NY |
| GRAHAM ANDERSON | Promoter | NEW YORK, NY |
| MARK CHAD GLASGOLD | Director | PRINCETON, NJ |
| John Li Walker | Executive Officer | New York, NY |
| John Li Walker | Promoter | New York, NY |
| Robert Li McClennan | Executive Officer | New York, NY |
| Robert Li McClennan | Promoter | New York, NY |
| Gregory Li Moran | Director | Columbus, OH |
| Christine Li Shuling | Executive Officer | Chiyoda-ku, Tokyo, M0 |
| Christine Li Shuling | Promoter | Chiyoda-ku, Tokyo, M0 |
| Mark Li Glasgold | Director | Princeton, NJ |
| Gregory E Moran | Director | Columbus, OH |
| Mark E Glasgold | Director | Princeton, NJ |
| William E Peterson | Director | Fairfax, VA |
Other filings by this issuer (6)
More